Superior Vena Cava Syndrome and Wallstent: A Systematic Review
Ali Kordzadeh, Alan Askari, Muhammad Hanif, Vijay M. Gadhvi
Abstract
The use of Wallstent for resolution of malignancy induced SVC syndrome as a first line therapy is feasible and associated with low mortality. Their use for non-malignant aetiology demands a more in depth review and advocates further investigation.
Topics & Concepts
MedicineSuperior vena cava syndromeInferior vena cavaVena cavaSurgeryRadiologySuperior vena cavaCentral Venous Catheters and HemodialysisVenous Thromboembolism Diagnosis and ManagementVascular anomalies and interventions